BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10704001)

  • 1. Utilization of carbon disulphide for the analytical determination of betahistine hydrochloride and captopril in their pharmaceutical preparations.
    El Walily AF; Razak OA; Belal SF; Bakry RS
    J Pharm Biomed Anal; 1999 Nov; 21(2):439-49. PubMed ID: 10704001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation.
    Hosseinimehr SJ; Ebrahimi P; Hassani N; Mirzabeigi P; Amini M
    Boll Chim Farm; 2004; 143(6):249-51. PubMed ID: 15881803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive kinetic spectrophotometric method for the determination of captopril in bulk and dosage forms.
    Rahman N; Anwar N; Kashif M; Hoda N
    Acta Pharm; 2006 Sep; 56(3):347-57. PubMed ID: 19831283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation methods for captopril in pharmaceuticals and biological fluids.
    Mansour FR; Danielson ND
    J Sep Sci; 2012 Jun; 35(10-11):1213-26. PubMed ID: 22733503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of oxidation reactions for the spectrophotometric determination of captopril using brominating agents.
    El-Didamony AM; Erfan EA
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Mar; 75(3):1138-45. PubMed ID: 20080436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalysis reaction between sodium 1,2-naphthoquinone-4-sulfonate and hydroxyl ion using captopril as catalyzer and determination of captopril.
    Gao L; Wu L; Li Q
    Anal Chim Acta; 2008 Sep; 626(2):174-9. PubMed ID: 18790118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect determination of captopril by AAS.
    El Reis MA; Abou Attia FM; Kenawy IM
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):249-54. PubMed ID: 10933517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting kinetic spectrophotometric determination of captopril, an angiotensin-converting enzyme inhibitor, in a multi-pumping flow system.
    Prior JA; Santos JL; Lima JL
    Anal Chim Acta; 2007 Sep; 600(1-2):183-7. PubMed ID: 17903482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a capillary electrophoresis method with laser-induced fluorescence detection for the determination of captopril in human urine and pharmaceutical preparations.
    Pérez-Ruiz T; Martínez-Lozano C; Galera R
    Electrophoresis; 2006 Jun; 27(12):2310-6. PubMed ID: 16718646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parafac and PLS applied to determination of captopril in pharmaceutical preparation and biological fluids by ultraviolet spectrophotometry.
    Niazi A; Ghasemi N
    Ann Chim; 2007 Sep; 97(9):845-58. PubMed ID: 17970300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-DAD method for the simultaneous determination of zofenopril and hydrochlorothiazide in oral pharmaceutical formulations.
    Carlucci G; Di Federico L; Iuliani P
    J Sep Sci; 2010 Jun; 33(12):1717-22. PubMed ID: 20437414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu(II).
    Abdellatef HE; Ayad MM; Taha EA
    J Pharm Biomed Anal; 1999 Jan; 18(6):1021-7. PubMed ID: 9925338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of captopril in pharmaceutical tablets by anion-exchange HPLC using indirect photometric detection; a study in systematic method development.
    Mirza T; Tan HS
    J Pharm Biomed Anal; 2001 Apr; 25(1):39-52. PubMed ID: 11274857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser induced thermal lens microscopy for highly sensitive determination of captopril.
    Shokoufi N; Abbasi-Ahd A; Kargosha K
    Appl Opt; 2017 Apr; 56(11):E58-E63. PubMed ID: 28414342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and determination of selected medicines reducing hypertension by densitometric and gas chromatographic methods.
    Czerwińska K; Wyszomirska E; Kaniewska T
    Acta Pol Pharm; 2001; 58(5):331-8. PubMed ID: 11876439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral characteristic investigation on complex of Ni (II) with captopril and its analytical application.
    Wei X; Du L; Li D; Gong Q; Wang L; Lin Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Aug; 94():12-7. PubMed ID: 22510489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of captopril on a coated capillary by capillary electrophoresis.
    Hillaert S; Van den Bossche W
    J Pharm Belg; 1999; 54(3):83-4. PubMed ID: 10431475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of simultaneous volumetric and spectrophotometric methods for the determination of captopril in pharmaceutical formulations.
    Rahman N; Singh M; Hoda N
    Farmaco; 2005; 60(6-7):569-74. PubMed ID: 15927181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of captopril and its disulphides in whole human blood and urine by high-performance liquid chromatography with ultraviolet detection and precolumn derivatization.
    Sypniewski S; Bald E
    J Chromatogr A; 1996 Apr; 729(1-2):335-40. PubMed ID: 9004958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of captopril and prednisolone in tablets by FT-Raman spectroscopy.
    Mazurek S; Szostak R
    J Pharm Biomed Anal; 2006 Mar; 40(5):1225-30. PubMed ID: 16253463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.